Biopsy of recurrent nasolacrimal duct obstruction using sheath-guided dacryoendoscopy

Kosuke Ueda, Akihide Watanabe, Norihiko Yokoi, Manabu Sugimoto, Hideki Fukuoka, Katsuhiko Shinomiya, Shigeru Kinoshita, Saul Rajak, Dinesh Selva

Research output: Contribution to journalArticle

Abstract

Purpose: The purpose of this article is to present a novel technique, as well the histopathological findings, of dacryoendoscopic guided nasolacrimal duct (NLD) biopsy for recurrent nasolacrimal duct obstruction (NLDO). Methods: This study involved subjects with recurrent NLDO. Direct endoscopic probing or sheath-guided endoscopic probing was used for the initial intubation in all treated eyes, and the stent had been removed at between 2 and 11 months (mean 3.5 months) post-intubation with dacryoendoscopic confirmation of patency and mucosal regeneration. Biopsy specimens were obtained by scraping the recurrent lesion by sheath advancement. Histopathological examination and immunohistochemical (IHC) staining were performed. Results: In five patients (two males and three females, mean age: 71.2 ± 5.6 years [range: 61–78 years]) with recurrent NLDO, biopsy specimens were obtained from six ducts of six eyes, and stratified epithelium and a mixed inflammatory cell infiltrates were identified. IHC staining was positive for cytokeratin (CK)4 and CK13, and negative for paired box protein Pax-6. Conclusions: This novel technique enabled a minimally invasive biopsy of the NLD to be obtained, and IHC staining indicated the presence of mucus epithelium, thus suggesting squamous metaplasia of the usual respiratory epithelium which likely occurs secondary to chronic inflammation.

Original languageEnglish
JournalOrbit (London)
DOIs
Publication statusAccepted/In press - Jan 1 2018
Externally publishedYes

Fingerprint

Nasolacrimal Duct
Biopsy
Staining and Labeling
Intubation
Keratin-4
Epithelium
Respiratory Mucosa
Metaplasia
Mucus
Stents
Regeneration
Inflammation

Keywords

  • biopsy
  • Dacryoendoscopy
  • immunohistochemistry
  • nasolacrimal duct obstruction
  • sheath-guided endoscopic probing (SEP)

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Biopsy of recurrent nasolacrimal duct obstruction using sheath-guided dacryoendoscopy. / Ueda, Kosuke; Watanabe, Akihide; Yokoi, Norihiko; Sugimoto, Manabu; Fukuoka, Hideki; Shinomiya, Katsuhiko; Kinoshita, Shigeru; Rajak, Saul; Selva, Dinesh.

In: Orbit (London), 01.01.2018.

Research output: Contribution to journalArticle

Ueda, Kosuke ; Watanabe, Akihide ; Yokoi, Norihiko ; Sugimoto, Manabu ; Fukuoka, Hideki ; Shinomiya, Katsuhiko ; Kinoshita, Shigeru ; Rajak, Saul ; Selva, Dinesh. / Biopsy of recurrent nasolacrimal duct obstruction using sheath-guided dacryoendoscopy. In: Orbit (London). 2018.
@article{186fae6610cb4c9d8ed377da2556df0b,
title = "Biopsy of recurrent nasolacrimal duct obstruction using sheath-guided dacryoendoscopy",
abstract = "Purpose: The purpose of this article is to present a novel technique, as well the histopathological findings, of dacryoendoscopic guided nasolacrimal duct (NLD) biopsy for recurrent nasolacrimal duct obstruction (NLDO). Methods: This study involved subjects with recurrent NLDO. Direct endoscopic probing or sheath-guided endoscopic probing was used for the initial intubation in all treated eyes, and the stent had been removed at between 2 and 11 months (mean 3.5 months) post-intubation with dacryoendoscopic confirmation of patency and mucosal regeneration. Biopsy specimens were obtained by scraping the recurrent lesion by sheath advancement. Histopathological examination and immunohistochemical (IHC) staining were performed. Results: In five patients (two males and three females, mean age: 71.2 ± 5.6 years [range: 61–78 years]) with recurrent NLDO, biopsy specimens were obtained from six ducts of six eyes, and stratified epithelium and a mixed inflammatory cell infiltrates were identified. IHC staining was positive for cytokeratin (CK)4 and CK13, and negative for paired box protein Pax-6. Conclusions: This novel technique enabled a minimally invasive biopsy of the NLD to be obtained, and IHC staining indicated the presence of mucus epithelium, thus suggesting squamous metaplasia of the usual respiratory epithelium which likely occurs secondary to chronic inflammation.",
keywords = "biopsy, Dacryoendoscopy, immunohistochemistry, nasolacrimal duct obstruction, sheath-guided endoscopic probing (SEP)",
author = "Kosuke Ueda and Akihide Watanabe and Norihiko Yokoi and Manabu Sugimoto and Hideki Fukuoka and Katsuhiko Shinomiya and Shigeru Kinoshita and Saul Rajak and Dinesh Selva",
year = "2018",
month = "1",
day = "1",
doi = "10.1080/01676830.2018.1513536",
language = "English",
journal = "Orbit",
issn = "0167-6830",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Biopsy of recurrent nasolacrimal duct obstruction using sheath-guided dacryoendoscopy

AU - Ueda, Kosuke

AU - Watanabe, Akihide

AU - Yokoi, Norihiko

AU - Sugimoto, Manabu

AU - Fukuoka, Hideki

AU - Shinomiya, Katsuhiko

AU - Kinoshita, Shigeru

AU - Rajak, Saul

AU - Selva, Dinesh

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: The purpose of this article is to present a novel technique, as well the histopathological findings, of dacryoendoscopic guided nasolacrimal duct (NLD) biopsy for recurrent nasolacrimal duct obstruction (NLDO). Methods: This study involved subjects with recurrent NLDO. Direct endoscopic probing or sheath-guided endoscopic probing was used for the initial intubation in all treated eyes, and the stent had been removed at between 2 and 11 months (mean 3.5 months) post-intubation with dacryoendoscopic confirmation of patency and mucosal regeneration. Biopsy specimens were obtained by scraping the recurrent lesion by sheath advancement. Histopathological examination and immunohistochemical (IHC) staining were performed. Results: In five patients (two males and three females, mean age: 71.2 ± 5.6 years [range: 61–78 years]) with recurrent NLDO, biopsy specimens were obtained from six ducts of six eyes, and stratified epithelium and a mixed inflammatory cell infiltrates were identified. IHC staining was positive for cytokeratin (CK)4 and CK13, and negative for paired box protein Pax-6. Conclusions: This novel technique enabled a minimally invasive biopsy of the NLD to be obtained, and IHC staining indicated the presence of mucus epithelium, thus suggesting squamous metaplasia of the usual respiratory epithelium which likely occurs secondary to chronic inflammation.

AB - Purpose: The purpose of this article is to present a novel technique, as well the histopathological findings, of dacryoendoscopic guided nasolacrimal duct (NLD) biopsy for recurrent nasolacrimal duct obstruction (NLDO). Methods: This study involved subjects with recurrent NLDO. Direct endoscopic probing or sheath-guided endoscopic probing was used for the initial intubation in all treated eyes, and the stent had been removed at between 2 and 11 months (mean 3.5 months) post-intubation with dacryoendoscopic confirmation of patency and mucosal regeneration. Biopsy specimens were obtained by scraping the recurrent lesion by sheath advancement. Histopathological examination and immunohistochemical (IHC) staining were performed. Results: In five patients (two males and three females, mean age: 71.2 ± 5.6 years [range: 61–78 years]) with recurrent NLDO, biopsy specimens were obtained from six ducts of six eyes, and stratified epithelium and a mixed inflammatory cell infiltrates were identified. IHC staining was positive for cytokeratin (CK)4 and CK13, and negative for paired box protein Pax-6. Conclusions: This novel technique enabled a minimally invasive biopsy of the NLD to be obtained, and IHC staining indicated the presence of mucus epithelium, thus suggesting squamous metaplasia of the usual respiratory epithelium which likely occurs secondary to chronic inflammation.

KW - biopsy

KW - Dacryoendoscopy

KW - immunohistochemistry

KW - nasolacrimal duct obstruction

KW - sheath-guided endoscopic probing (SEP)

UR - http://www.scopus.com/inward/record.url?scp=85052286296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052286296&partnerID=8YFLogxK

U2 - 10.1080/01676830.2018.1513536

DO - 10.1080/01676830.2018.1513536

M3 - Article

C2 - 30142018

AN - SCOPUS:85052286296

JO - Orbit

JF - Orbit

SN - 0167-6830

ER -